Condensed Statements of Operations and Comprehensive Loss (unaudited) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Operating expenses:
Research and development	$ 12,536	$ 8,921	$ 21,066	$ 16,042
General and administrative	3,106	2,646	6,538	5,145
Total operating expenses	15,642	11,567	27,604	21,187
Loss from operations	(15,642)	(11,567)	(27,604)	(21,187)
Interest income, net	660	127	1,176	159
Other income (expense)	(17)	33	(27)	24
Net loss	$ (14,999)	$ (11,407)	$ (26,455)	$ (21,004)
Net loss per share, basic	$ (0.65)	$ (0.67)	$ (1.22)	$ (1.23)
Net loss per share, Diluted	$ (0.65)	$ (0.67)	$ (1.22)	$ (1.23)
Weighted Average Number of Shares Outstanding, Basic	22,968,920	17,130,307	21,696,427	17,108,582
Weighted Average Number of Shares Outstanding, Diluted	22,968,920	17,130,307	21,696,427	17,108,582
Comprehensive loss:
Net loss	$ (14,999)	$ (11,407)	$ (26,455)	$ (21,004)
Unrealized gain (loss) on short-term investments	131	(188)	402	(620)
Comprehensive loss	$ (14,868)	$ (11,595)	$ (26,053)	$ (21,624)